For research use only. Not for therapeutic Use.
LC-MB12（Cat No.:I041094）is a small molecule compound under investigation for its potential therapeutic applications in cancer treatment. It works by targeting specific proteins involved in regulating cell growth, survival, and apoptosis. LC-MB12 has demonstrated preclinical efficacy in inhibiting tumor cell proliferation and inducing apoptosis in various cancer models. Its mechanism of action suggests it could be effective in treating cancers with aberrant signaling pathways or resistance to traditional therapies. LC-MB12 is being explored for its potential to enhance the effectiveness of existing treatments and provide a targeted approach in oncology.
| CAS Number | 2828438-38-4 |
| Synonyms | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-[4-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidine-4-carbonyl]piperazin-1-yl]anilino]pyrimidin-4-yl]-1-methylurea |
| Molecular Formula | C43H44Cl2N10O8 |
| Purity | ≥95% |
| IUPAC Name | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-[4-[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidine-4-carbonyl]piperazin-1-yl]anilino]pyrimidin-4-yl]-1-methylurea |
| InChI | InChI=1S/C43H44Cl2N10O8/c1-51(43(61)50-38-36(44)31(62-2)21-32(63-3)37(38)45)34-22-33(46-23-47-34)48-25-4-6-26(7-5-25)53-16-18-54(19-17-53)40(58)24-12-14-52(15-13-24)27-8-9-28-29(20-27)42(60)55(41(28)59)30-10-11-35(56)49-39(30)57/h4-9,20-24,30H,10-19H2,1-3H3,(H,50,61)(H,46,47,48)(H,49,56,57) |
| InChIKey | BUEXWHUMUYQITQ-UHFFFAOYSA-N |
| SMILES | CN(C1=NC=NC(=C1)NC2=CC=C(C=C2)N3CCN(CC3)C(=O)C4CCN(CC4)C5=CC6=C(C=C5)C(=O)N(C6=O)C7CCC(=O)NC7=O)C(=O)NC8=C(C(=CC(=C8Cl)OC)OC)Cl |
